The Online Investor

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Sat., May. 8, 5:52 AM

Slide #7. Syneos Health, Inc. Secondary Offering

Company: Syneos Health, Inc. (NASDAQ:SYNH)
Date announced: 5/3/2021
Shares Offered: 7,000,000
Date of Pricing: 5/3/2021
Price Per Share: $79.80
Secondary Offering Details: Syneos Health, Inc. (Nasdaq: SYNH) (the "Company" or "Syneos Health"), the only fully integrated biopharmaceutical solutions organization, today announced it commenced an underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporation (the "Selling Stockholders") of an aggregate of 7,000,000 shares of the Company's common stock (the "Offering") pursuant to the Company's shelf registration statement filed with the Securities and Exchange Commission ("SEC"). The Selling Stockholders intend to grant the underwriter a 30-day option to purchase up to 1,050,000 additional shares of common stock. Syneos Health is not selling any shares and will not receive any proceeds from the sale of the shares by the Selling Stockholders in the Offering. -updated 5/3- Syneos Health, Inc. (Nasdaq: SYNH) (the "Company" or "Syneos Health"), the only fully integrated biopharmaceutical solutions organization, today announced the pricing of the previously announced underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporation (the "Selling Stockholders") of an aggregate of 7,000,000 shares of the Company's common stock (the "Offering"). The Selling Stockholders have also granted the underwriter a 30-day option to purchase up to 1,050,000 additional shares of common stock. Syneos Health is not selling any shares and will not receive any proceeds from the proposed sale of the shares by the Selling Stockholders in the Offering. The Offering is expected to close on May 6, 2021, subject to customary closing conditions.

Syneos Health is a holding company. Through its subsidiaries, Co. is a biopharmaceutical solutions organization providing a suite of clinical and commercial services to customers in the biopharmaceutical, biotechnology, and medical device industries. Co. has two reportable segments: Clinical Solutions, which provides a variety of clinical development services spanning Phase I to Phase IV, including global studies, unbundled service offerings, and Real World Evidence studies; and Commercial Solutions, which provides customers with a range of commercialization services, including field teams and medication adherence services, communications solutions, and consulting services.

SYNH SEC Filing Email Alerts Service

Open the SYNH Page at The Online Investor »

Company Name: 
Syneos Health Inc
Website: 
www.syneoshealth.com
Sector: 
Biotechnology
Number of ETFs Holding SYNH: 
60
Total Market Value Held by ETFs: 
$1.11B
Total Market Capitalization: 
$8.48B
% of Market Cap. Held by ETFs: 
13.12%
 

Open the SYNH Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Strong Buy (3.75 out of 4)
70th percentile
(ranked higher than approx. 70% of all stocks covered)

Analysts' Target Price:
SYNH Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.